Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

Oncoimmunology. 2020 Apr 17;9(1):1751561. doi: 10.1080/2162402X.2020.1751561. eCollection 2020.

Abstract

Staphylococcus aureus and its toxins have been linked to disease progression and mortality in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role in anti-cancer responses and high CD8+ T cell numbers in tumor lesions are associated with a favorable prognosis in CTCL. Here, we show that CD8+ T cells from both healthy donors and Sézary syndrome patients are highly susceptible to cell death induced by Staphylococcal alpha-toxin, whereas malignant T cells are not. Importantly, alpha-toxin almost completely blocks cytotoxic killing of CTCL tumor cells by peptide-specific CD8+ T cells, leading to their escape from induced cell death and continued proliferation. These findings suggest that alpha-toxin may favor the persistence of malignant CTCL cells in vivo by inhibiting CD8+ T cell cytotoxicity. Thus, we propose a novel mechanism by which colonization with Staphylococcus aureus may contribute to cancer immune evasion and disease progression in CTCL.

Keywords: Alpha-toxin; CD8+ T cells; CTCL; Staphylococcus aureus; cytotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Toxins*
  • CD8-Positive T-Lymphocytes* / drug effects
  • CD8-Positive T-Lymphocytes* / immunology
  • Hemolysin Proteins*
  • Humans
  • Leukocytes, Mononuclear
  • Lymphoma, T-Cell, Cutaneous* / immunology
  • Skin Neoplasms* / immunology
  • Staphylococcus aureus

Substances

  • Bacterial Toxins
  • Hemolysin Proteins
  • staphylococcal alpha-toxin